Jill DeSimone's Insider Trades & SAST Disclosures
Jill DeSimone's most recent trade in Oncternal Therapeutics Inc was a trade of 2,200 Stock Options done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jill DeSimone.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| ITeos Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,200 | 24,200 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,566 | 8,566 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 44,766 | 44,766 | - | - | Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
| Praxis Precision Medicines... | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 28,981 | 28,981 | - | - | Stock Option (Right to Buy) | |
| Kinnate Biopharma Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option | |
| Praxis Precision Medicines... | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 45,511 | 45,511 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges